Design, Synthesis and Study of New Sensitizers for Pdt


NIH 2004 R01 CA	Design, Synthesis and Study of New Sensitizers for PDT Detty, Michael R. / State University of New York at Buffalo	$215,645
NIH 2003 R01 CA	Design, Synthesis and Study of New Sensitizers for PDT Detty, Michael R. / State University of New York at Buffalo	$217,097
NIH 2002 R01 CA	Design, Synthesis and Study of New Sensitizers for PDT Detty, Michael R. / State University of New York at Buffalo	$217,888
NIH 2001 R01 CA	Design, Synthesis and Study of New Sensitizers for PDT Detty, Michael R. / State University of New York at Buffalo	$237,061
NIH 1998 R01 CA	Design, Synthesis and Study of New Sensitizers for Pdt Detty, Michael R. / State University of New York at Buffalo
NIH 1997 R01 CA	Design, Synthesis and Study of New Sensitizers for Pdt Detty, Michael R. / State University of New York at Buffalo
NIH 1996 R01 CA	Design, Synthesis and Study of New Sensitizers for Pdt Detty, Michael R. / State University of New York at Buffalo

Wagner, Stephen J; Skripchenko, Andrey; Donnelly, David J et al. (2005) Chalcogenoxanthylium photosensitizers for the photodynamic purging of blood-borne viral and bacterial pathogens. Bioorg Med Chem 13:5927-35

Detty, Michael R; Prasad, Paras N; Donnelly, David J et al. (2004) Synthesis, properties, and photodynamic properties in vitro of heavy-chalcogen analogues of tetramethylrosamine. Bioorg Med Chem 12:2537-44

Detty, Michael R; Gibson, Scott L; Wagner, Stephen J (2004) Current clinical and preclinical photosensitizers for use in photodynamic therapy. J Med Chem 47:3897-915

Brennan, Nancy K; Donnelly, David J; Detty, Michael R (2003) Selenoxanthones via directed metalations in 2-arylselenobenzamide derivatives. J Org Chem 68:3344-7

Brennan, Nancy K; Hall, Jonathan P; Davies, Sherry R et al. (2002) In vitro photodynamic properties of chalcogenopyrylium analogues of the thiopyrylium antitumor agent AA1. J Med Chem 45:5123-35

Showing the most recent 10 out of 12 publications